Abstract
The biliary penetration of cefamandole was studied in six patients with total biliary obstruction before and after placement of a transhepatic bile drainage catheter. Biliary levels of cefamandole remained depressed even when the drug was administered as late as 7 days after decompression of the biliary tract.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Brogard J. M., Pinget M., Arnaud J. P., Dorner M., Adloff M., Lavillaureix J. Etude expérimentale et clinique de l'élimination billaire du céfamandole. Pathol Biol (Paris) 1981 Jan;29(1):25–30. [PubMed] [Google Scholar]
- Levi J. U., Livingstone A. S., Martinez O. V., Zeppa R., Malinin T., Hutson D. G., Einhorn N. C. Biliary concentrations of cefamandole and its use in biliary tract surgery. Scand J Infect Dis Suppl. 1980;Suppl 25:55–57. [PubMed] [Google Scholar]
- Lindahl F., Kjaer T. B., Thomsen V. F. Excretion of cefamandole in the bile. Scand J Infect Dis Suppl. 1980;Suppl 25:58–59. [PubMed] [Google Scholar]
- Martinez O. V., Levi J. U., Devlin R. G. Biliary excretion of aztreonam in patients with biliary tract disease. Antimicrob Agents Chemother. 1984 Mar;25(3):358–361. doi: 10.1128/aac.25.3.358. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Quintiliani R., French M., Nightingale C. H. First and second generation cephalosporins. Med Clin North Am. 1982 Jan;66(1):183–197. doi: 10.1016/s0025-7125(16)31452-3. [DOI] [PubMed] [Google Scholar]